Quarterly report pursuant to Section 13 or 15(d)

DISCONTINUED OPERATIONS

v3.21.2
DISCONTINUED OPERATIONS
6 Months Ended
Jun. 30, 2021
DISCONTINUED OPERATIONS  
NOTE 16. DISCONTINUED OPERATIONS

NOTE 16 – DISCONTINUED OPERATIONS

 

On May 8, 2019, MediFarm LLC, a wholly-owned subsidiary of the Company, entered into an Asset Purchase Agreement (the “Purchase Agreement”) with Picksy, LLC (the “Purchaser”) pursuant to which the Company agreed to sell and the Purchaser agreed to purchase substantially all of the assets of the Company related to the Company’s dispensary located at 1130 East Desert Inn Road, Las Vegas, NV 89109 (the “Business”). The aggregate consideration to be paid for the Business is $10.00 million, of which $7.20 million is cash (the “Purchase Price”). A portion of the Purchase Price is payable by the Purchaser pursuant to a 12 month Secured Promissory Note with a principal amount of $2.80 million (the “Note”). The Note is secured by all the assets sold pursuant to the Purchase Agreement. In conjunction with the Note, Purchaser and the Company entered into a Security Agreement granting the Company a security interest in all the assets sold pursuant to the Purchase Agreement. The transaction has been approved by the Nevada Department of Taxation and is awaiting local government approval which is being impacted by COVID-19. It is expected to close promptly following receipt of such approval.

 

On August 19, 2019, MediFarm I LLC, a wholly-owned subsidiary of the Company, entered into an Asset Purchase Agreement (the “Purchase Agreement”) with Picksy Reno, LLC (the “Purchaser”) pursuant to which the Company agreed to sell and the Purchaser agreed to purchase substantially all of the assets of the Company related to the Company’s dispensary located at 1085 S Virginia St Suite A, Reno, NV 89502 (the “Business”). The aggregate consideration to be paid for the Business is $13.50 million, of which $9.30 million is cash (the “Purchase Price”). A portion of the Purchase Price is payable by the Purchaser pursuant to a 12 month Secured Promissory Note with a principal amount of $4.20 million (the “Note”). The Note is secured by all the assets sold pursuant to the Purchase Agreement. In conjunction with the Note, Purchaser and the Company entered into a Security Agreement granting the Company a security interest in all the assets sold pursuant to the Purchase Agreement. The transaction has been approved by the Nevada Department of Taxation and is awaiting local government approval which is being impacted by COVID-19. It is expected to close promptly following receipt of such approval.

On April 15, 2020, MediFarm LLC, a wholly-owned subsidiary of the Company, entered into an Asset Purchase Agreement (the “Purchase Agreement”) with Natural Medicine, LLC, a nonaffiliated third party (the “Purchaser”) pursuant to which the Company agreed to sell and the Purchaser agreed to purchase substantially all of the assets of the Company related to the Company’s dispensary located at 3650 S. Decatur Blvd., Las Vegas, NV. The aggregate consideration to be paid for the Business is $5.25 million, of which $2.50 million is cash and $2.75 million is payable by the Purchaser pursuant to a 12-month Secured Promissory Note bearing 8% interest per annum, which is secured by all of the assets sold pursuant to the Purchase Agreement. The transaction has been approved by the Nevada Department of Taxation and is awaiting local government approval which is being impacted by COVID-19. It is expected to close promptly following receipt of such approval. The Company will recognize a gain upon completion of the sale of the assets, equal to the difference between the consideration paid and the book value of the assets as of the disposition date, less direct costs to sell, and reflect such loss in discontinued operations.

 

As of June 30, 2021, Management has classified a real estate asset held Nevada as available-for-sale, as it has met the criteria of ASC 360-10-45-9.

 

The pending sales of our Nevada dispensaries, expected sale of real estate, and assets divested during 2020 represent a strategic shift that will have a major effect on the Company’s operations and financial results. As a result, Management determined the results of these components qualified for discontinued operations presentation in accordance with ASC 205, “Reporting Discontinued Operations and Disclosure of Disposals of Components of an Entity.”

 

During 2020, Management suspended the operations of OneQor Technologies due to (i) a lack of proper growth in customer acquisition and revenue for this CBD operation during the COVID-19 pandemic and (ii) the overall financial health of the Company as a result of COVID-19 and social unrest. The Company plans to focus its attention and resources on growing its THC business.

 

Operating results for the discontinued operations were comprised of the following:

 

 

 

(in thousands)

 

 

(in thousands)

 

 

 

Three Months Ended
June 30,

 

 

Six Months Ended
June 30,

 

 

 

2021

 

 

2020

 

 

2021

 

 

2020

 

Total revenues

 

$ -

 

 

$ 699

 

 

$ -

 

 

$ 3,275

 

Cost of goods sold

 

 

-

 

 

 

621

 

 

 

-

 

 

 

2,661

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gross profit

 

 

-

 

 

 

78

 

 

 

-

 

 

 

614

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Selling, general and administrative expenses

 

 

58

 

 

 

1,274

 

 

 

58

 

 

 

3,868

 

Impairment of assets

 

 

-

 

 

 

6,316

 

 

 

-

 

 

 

6,316

 

Loss on sale of assets

 

 

-

 

 

 

9

 

 

 

-

 

 

 

3,197

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Income (Loss) from operations

 

$ (58 )

 

$ (7,521 )

 

$ (58 )

 

$ (12,767 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Interest expense

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other income (loss)

 

 

2

 

 

 

(387 )

 

 

15

 

 

 

(376 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Income (Loss) from discontinued operations

 

$ (56 )

 

$ (7,908 )

 

$ (43 )

 

$ (13,143 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Income (Loss) from discontinued operations per common share attributable to Unrivaled Brands, Inc. common stockholders - basic and diluted

 

$ (0.00 )

 

$ (0.04 )

 

$ (0.00 )

 

$ (0.08 )

The carrying amounts of the major classes of assets and liabilities for the discontinued operations are as follows:

 

 

 

(in thousands)

 

 

 

June 30,
 2021

 

 

December 31,

2020

 

Prepaid expenses and other assets

 

$ -

 

 

$ 2

 

Property, equipment and leasehold improvements, net

 

 

2,765

 

 

 

2,766

 

Intangible assets, net

 

 

-

 

 

 

-

 

Goodwill

 

 

-

 

 

 

-

 

Other assets

 

 

136

 

 

 

186

 

Assets of discontinued operations

 

$ 2,901

 

 

$ 2,954

 

 

 

 

 

 

 

 

 

 

Accounts payable and accrued expenses

 

$ 823

 

 

$ 985

 

Deferred gain on sale of assets

 

 

13,533

 

 

 

8,783

 

Long-term lease liabilities

 

 

-

 

 

 

28

 

Liabilities of discontinued operations

 

$ 14,356

 

 

$ 9,796